For research use only. Not for therapeutic Use.
Tetraglycine is a oligopeptide composed of four glycine monomers[1].
Tetraglycine and Triglycine (1.0 μmol glycine/g body wt (246.22 mg/kg), injected into a central vein) results in greater glycine concentration in the kidney than injection of either Glycine (HY-Y0966) or Diglycine[1].
| Catalog Number | I042717 |
| CAS Number | 637-84-3 |
| Synonyms | 2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetic acid |
| Molecular Formula | C8H14N4O5 |
| Purity | ≥95% |
| InChI | InChI=1S/C8H14N4O5/c9-1-5(13)10-2-6(14)11-3-7(15)12-4-8(16)17/h1-4,9H2,(H,10,13)(H,11,14)(H,12,15)(H,16,17) |
| InChIKey | QMOQBVOBWVNSNO-UHFFFAOYSA-N |
| SMILES | C(C(=O)NCC(=O)NCC(=O)NCC(=O)O)N |
| Reference | [1]. Adibi SA, et al. Enrichment of glycine pool in plasma and tissues by glycine, di-, tri-, and tetraglycine. Am J Physiol. 1982 Nov;243(5):E413-7. |
